[Federal Register Volume 72, Number 247 (Thursday, December 27, 2007)]
[Notices]
[Page 73358]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-25051]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on July 20, 2007, GE Healthcare, 
3350 North Ridge Avenue, Arlington Heights, Illinois 60004-1412, made 
application to the Drug Enforcement Administration (DEA) to be 
registered as a bulk manufacturer of a substance controlled under the 
basic class of Cocaine (9041), a schedule II controlled substance.
    The company plans to manufacture a radioactive product used in 
diagnostic imaging in the diagnosis of Parkinson's Disease and for 
manufacture in bulk for investigational new drug (IND) submission and 
clinical trials.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Drug Enforcement 
Administration, Office of Diversion Control, Federal Register 
Representative (ODL), Washington, DC 20537, or any being sent via 
express mail should be sent to Drug Enforcement Administration, Office 
of Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, VA 22152; and must be filed no later 
than February 25, 2008.

    Dated: December 17, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control Drug 
Enforcement Administration.
 [FR Doc. E7-25051 Filed 12-26-07; 8:45 am]
BILLING CODE 4410-09-P